Company: PHARMABEST INCORPORATEDLast updated:Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD SUPPLEMENT — no approved therapeutic claims. Not a substitute for prescribed treatment.
CKD · dialysis · transplant
Kidney notes
Venamax is registered as alpha-lipoic acid, gamma-linolenic acid, vitamins, selenium and zinc. The FDA record does not itemize the vitamins or their amounts.
Evidence
No clinical trials of Venamax itself were identified on PubMed.
Alpha-lipoic acid in kidney disease: in the PATH trial, 353 hemodialysis patients randomized to mixed tocopherols plus alpha-lipoic acid 600 mg/day or placebo for 6 months showed no effect on CRP, IL-6, oxidative-stress markers or erythropoietin response, with similar mortality and hospitalization (Himmelfarb 2014). A pilot RCT in CKD stages 3 to 4 also found no change in these markers (Ramos 2011).
No trials of gamma-linolenic acid for kidney outcomes were identified.
Cautions in kidney disease
Ask for the full vitamin and mineral content before use: the FDA record does not list which vitamins are included or their amounts.
Registered as a food supplement with no approved therapeutic claims; content and dose are not verified like a drug.
Bottom line
The best kidney trial of its main antioxidant ingredient (PATH) was negative. No basis to recommend it for kidney protection; check the vitamin content before a patient with advanced CKD takes it.
Sources
Himmelfarb, J., Ikizler, T. A., Ellis, C., Wu, P., Shintani, A., Dalal, S., Kaplan, M., Chonchol, M., & Hakim, R. M. (2014). Provision of antioxidant therapy in hemodialysis (PATH): A randomized clinical trial. Journal of the American Society of Nephrology, 25(3), 623–633. https://doi.org/10.1681/ASN.2013050545
Ramos, L. F., Kane, J., McMonagle, E., Le, P., Wu, P., Shintani, A., Ikizler, T. A., & Himmelfarb, J. (2011). Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. Journal of Renal Nutrition, 21(3), 211–218. https://doi.org/10.1053/j.jrn.2010.08.003
Reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. renalcarematters.com, reviewed
FDA Philippines registration
1 current food-supplement registration under the brand VENAMAX. Registration status changes;
confirm a product's current status on the FDA verification portal using its FR number.
Registered drug products that share an ingredient with this supplement. A drug registration carries approved indications
and labeling; a food supplement does not, and its content and quality are not verified in the same way.
For health professionals. Data come from the FDA Philippines food-product
registration database and may lag behind the official record. A food-supplement registration means the product may be sold as food; it is not an approval of safety or efficacy for any disease. Not a substitute for clinical judgment.